Print
Email
Print Edition StoriesAvecia Biotechnology Inc., a DNA- and RNA-based therapeutics firm in Milford, has been acquired by Japanese materials manufacturer Nitto Denko Corp.
No financial terms of the deal were disclosed. The acquisition, which was conducted through Nitto’s New Jersey subsidiary Nitto Americas Inc., is expected to strengthen Nitto’s nucleic acid drug offerings, according to a news release from the Japanese firm.
Avecia is a large-scale manufacturer and developer of nucleic acid drugs, which Nitto officials said are used to change gene expression. Nitto Denko Technical Corp., an Oceanside, Calif.-based subsidiary of the Japanese company, also focuses on nucleic acid drug technology.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
